摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(2-ethyl-1,3-dioxolan-2-yl)-N-methoxy-N-methylhexanamide | 942483-77-4

中文名称
——
中文别名
——
英文名称
6-(2-ethyl-1,3-dioxolan-2-yl)-N-methoxy-N-methylhexanamide
英文别名
——
6-(2-ethyl-1,3-dioxolan-2-yl)-N-methoxy-N-methylhexanamide化学式
CAS
942483-77-4
化学式
C13H25NO4
mdl
——
分子量
259.346
InChiKey
UGWAKTJWOISLRM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    18
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.92
  • 拓扑面积:
    48
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Discovery of 4-((1-(1H-imidazol-2-yl)alkoxy)methyl)pyridines as a new class of Trypanosoma cruzi growth inhibitors
    作者:Simona Ponzi、Alberto Bresciani、Marcel Kaiser、Valentina Nardi、Emanuela Nizi、Jesus M. Ontoria、Paola Pace、Giacomo Paonessa、Vincenzo Summa、Steven Harper
    DOI:10.1016/j.bmcl.2020.127052
    日期:2020.4
    The identification of a new series of growth inhibitors of Trypanosoma cruzi, the causative agent of Chagas' disease, is described. In vitro screening of a subset of compounds from our in-house compound collection against the parasite led to the identification of hit compound 1 with low micromolar inhibition of T. cruzi growth. SAR exploration on the hit compound led to the identification of compounds
    描述了查格氏锥虫(Chagas's病的病原体)的新系列生长抑制剂的鉴定。从我们内部的化合物库中对寄生虫进行化合物的子集的体外筛选,导致鉴定出对克氏锥虫生长具有低微摩尔抑制作用的命中化合物1。SAR探索了这种受打击的化合物,从而鉴定出显示出纳摩尔级寄生虫生长抑制作用(T. cruzi EC50≤100 nM)且对人细胞无细胞毒性(HeLa CC50> 50μM)的化合物。进一步的研究确定CYP51抑制(化合物11 CYP51 IC50 52 nM)是这种新型抗寄生虫药的可能作用机理。
  • Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors
    申请人:Istituto de Ricerche di Biologia Molecolare P. Angeletti SpA.
    公开号:US08026265B2
    公开(公告)日:2011-09-27
    The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts and tautomers thereof. Compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful for treating cellular proliferative diseases, including cancer. They are also useful for treating neurodegenerative diseases, mental retardation, schizophrenia, inflammatory diseases, restenosis, immune disorders, diabetes, cardiovascular disorders and asthma.
    本发明涉及式(I)的化合物及其药学上可接受的盐和互变异构体。本发明的化合物是组蛋白去乙酰化酶(HDAC)的抑制剂,可用于治疗细胞增殖性疾病,包括癌症。它们还可用于治疗神经退行性疾病、智力低下、精神分裂症、炎症性疾病、再狭窄、免疫障碍、糖尿病、心血管疾病和哮喘。
  • WO2007/72080
    申请人:——
    公开号:——
    公开(公告)日:——
  • A general approach to homochiral α-amino substituted bromo-heteroaromatics suitable for two-dimensional rapid analogue synthesis
    作者:Carsten Schultz-Fademrecht、Olaf Kinzel、István E. Markó、Tomas Pospisil、Silvia Pesci、Michael Rowley、Philip Jones
    DOI:10.1016/j.tet.2009.08.013
    日期:2009.11
    An efficient and general synthesis of homochiral alpha-amino substituted bromo-heteroaromatics B using a diastereoselective 1,2-addition has been developed. The obtained heteroaromatic intermediates allow for a rapid two-dimensional exploration of a new series of histone deacetylase inhibitors, through Suzuki-Miyaura cross-coupling reactions for the introduction of a second aromatic element, followed by global deprotection and derivatization of the amino group. (C) 2009 Published by Elsevier Ltd.
  • HETEROCYCLE SUBSTITUTED KETONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS
    申请人:ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A.
    公开号:EP1976834A2
    公开(公告)日:2008-10-08
查看更多